Evidence map›Paper›PMID 28592821›Full record

ArticleScientific reports2017

Development of a 3D angiogenesis model to study tumour - endothelial cell interactions and the effects of anti-angiogenic drugs.

Arno Amann, Marit Zwierzina, Stefan Koeck, Gabriele Gamerith, Elisabeth Pechriggl, Julia M Huber, Edith Lorenz, Jens M Kelm, Wolfgang Hilbe, Heinz Zwierzina and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Arno AmannMedical University of Innsbruck, Department of Internal Medicine V, Anichstraße 35, 6020, Innsbruck, Austria. arno.amann@tirol-kliniken.at.
Marit ZwierzinaMedical University of Innsbruck, Department of Plastic, Reconstructive and Aesthetic surgery, Anichstraße 35, 6020, Innsbruck, Austria.
Stefan KoeckMedical University of Innsbruck, Department of Internal Medicine V, Anichstraße 35, 6020, Innsbruck, Austria.
Gabriele GamerithMedical University of Innsbruck, Department of Internal Medicine V, Anichstraße 35, 6020, Innsbruck, Austria.
Elisabeth PechrigglMedical University of Innsbruck, Division of Clinical and Functional Anatomy, Department of Anatomy, Histology and Embryology, Müllerstraße 59, 6020, Innsbruck, Austria.
Julia M HuberMedical University of Innsbruck, Department of Internal Medicine V, Anichstraße 35, 6020, Innsbruck, Austria.
Edith LorenzMedical University of Innsbruck, Department of Internal Medicine V, Anichstraße 35, 6020, Innsbruck, Austria.
Jens M KelmInSphero AG, Wagistrasse 27, CH-8952, Schlieren, Switzerland.
Wolfgang HilbeWilhelminenspital, Medical Department, Centre for Oncology, Haematology and Palliative care, Motlearstraße 37, 1160, Vienna, Austria.
Heinz ZwierzinaMedical University of Innsbruck, Department of Internal Medicine V, Anichstraße 35, 6020, Innsbruck, Austria.
Johann KernTyrolean Cancer Research Institute, Innrain 66, 6020, Innsbruck, Austria.ORCID 0000-0003-4906-354X
Innsbruck Medical University · ATTyrolean Cancer Research Institute · ATWilhelminen Hospital · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumour microenvironment and tumour angiogenesis play a critical role in the development and therapy of many cancers, but in vitro models reflecting these circumstances are rare. In this study, we describe the development of a novel tri-culture model, using non-small cell lung cancer (NSCLC) cell lines (A549 and Colo699) in combination with a fibroblast cell line (SV 80) and two different endothelial cell lines in a hanging drop technology. Endothelial cells aggregated either in small colonies in Colo699 containing microtissues or in tube like structures mainly in the stromal compartment of microtissues containing A549. An up-regulation of hypoxia and vimentin, ASMA and a downregulation of E-cadherin were observed in co- and tri-cultures compared to monocultures. Furthermore, a morphological alteration of A549 tumour cells resembling "signet ring cells" was observed in tri-cultures. The secretion of proangiogenic growth factors like vascular endothelial growth factor (VEGF) was measured in supernatants. Inhibition of these proangiogenic factors by using antiangiogenic drugs (bevacizumab and nindetanib) led to a significant decrease in migration of endothelial cells into microtissues. We demonstrate that our method is a promising tool for the generation of multicellular tumour microtissues and reflects in vivo conditions closer than 2D cell culture.

Indexed as

Cell CommunicationModels, AnatomicNeovascularization, PathologicTumor MicroenvironmentCell Line, TumorCell MovementCell ProliferationCell SurvivalCell Transformation, NeoplasticCoculture TechniquesCytokinesEndothelial CellsHumansHuman Umbilical Vein Endothelial CellsImmunohistochemistryNeoplasmsCytokinesOxygenPlatelet Endothelial Cell Adhesion Molecule-1Vascular Endothelial Growth Factor A

Identifiers

PMID28592821
PMCPMC5462801
OpenAlexW2620579988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.